Oftalmologia (Bucharest, Romania : 1990) · 2010
[Modern therapy in blepharospasm].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bereş Aurora
Аннотация
PURPOSE: Pharmaceutical presentation of botulin A toxin (BAT) and its therapeutical use in ophthalmology in essential blepharospasm, as well. This work analyses the results and the disadvantages of the cure.
MATERIAL & METHODS: During the last 3 years 21 patients suffering of essential blepharospasm have been cured. The cure with botulin A toxin administrated in efficient doses is followed by a 3-4 months period of pause.
RESULTS: At all the patients cured with Dysport, the symptoms have improved or weakened. The cure should be done at least twice a year (from 6 to 6 months) due to the "sprouting" axonal phenomenon.
CONCLUSIONS: The treatment of essential blepharospasm with botulin A toxin is a reliable and efficient method, with results relatively quickly installed. In treating this disease, it should be chosen from the very beginning.
MATERIAL & METHODS: During the last 3 years 21 patients suffering of essential blepharospasm have been cured. The cure with botulin A toxin administrated in efficient doses is followed by a 3-4 months period of pause.
RESULTS: At all the patients cured with Dysport, the symptoms have improved or weakened. The cure should be done at least twice a year (from 6 to 6 months) due to the "sprouting" axonal phenomenon.
CONCLUSIONS: The treatment of essential blepharospasm with botulin A toxin is a reliable and efficient method, with results relatively quickly installed. In treating this disease, it should be chosen from the very beginning.